Raju Prasad

Insider Reports History

Entity
Individual
Location
Crispr Therapeutics, Inc., 105 W First Street, Boston, MA
Signature
/s/ AJ Silver, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Raju Prasad:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CRISPR Therapeutics AG Chief Financial Officer Common Shares 6.48K $471K $72.69 Mar 15, 2024 Direct
CRISPR Therapeutics AG Chief Financial Officer Stock Option (Right to Buy) 36.2K Mar 20, 2024 Direct
CRISPR Therapeutics AG Chief Financial Officer Restricted Stock Units 25K Mar 20, 2024 Direct

Insider Reports Filed by Raju Prasad

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRSP CRISPR Therapeutics AG Mar 20, 2024 2 $0 4 Mar 22, 2024 Chief Financial Officer
CRSP CRISPR Therapeutics AG Mar 14, 2024 3 -$256K 4 Mar 18, 2024 Chief Financial Officer
CRSP CRISPR Therapeutics AG Oct 13, 2023 1 $0 4 Oct 17, 2023 Chief Financial Officer
CRSP CRISPR Therapeutics AG Mar 14, 2023 2 $0 4 Mar 14, 2023 Chief Financial Officer
CRSP CRISPR Therapeutics AG Mar 14, 2023 0 $0 3 Mar 14, 2023 Chief Financial Officer